Please fill in the below information utilizing the attached financial statements

Current Assets:

Current Liabilities:

Total Liabilities:

Total Assets:

Total Revenue:

Net Income:

Shares Outstanding:

Stock Price:

EPS:

Shareholder's Equity:

NI. Pref. Div.:

Balance Sheet

Currency Aumtsmum Consolidated Scale Cash & cash equivalents Restricted cash Marketable securities Accounts receivable, trade, gross Less: allowances Accounts receivable, trade Rawr materials & supplies Goods in process Finished goods Inventories Prepaid expenses & other current assets Total current assets Property, plant 8; equipment at cost Less: accumulated depreciation Property, plant 8; equipment, net Intangible assets, net Goodwill Deferred taxes on income Other assets Total assets Loans 8; notes payable Accounts payable Accrued liabilities Accrued rebates, returns 8; promotions Accrued compensation & employee related obligations Accrued taxes on income Total current liabilities Notes Debentures Other long-term debt Long-term debt Deferred taxes on income Employee related obligations Long-term taxes payable Other liabilities Total liabilities Common stock Foreign currency translation Gain (loss) on securities Employee benefit plans Gain (loss) on derivatives & hedges Accumulated other comprehensive income (loss) Retained earnings & additional paid-in capital Retained earnings (accumulated deficit) Less: common stock held in treasury, at cost Total Johnson & Johnson shareholders? equity Total equity Equity attributable to non-controlling interest USD Unaudited Yes Thousands 21183000 7322000 16982000 205000 16777000 2419000 1944000 8525000 12888000 2397000 60567000 51218000 30642000 20576000 46246000 45440000 8779000 10078000 191686000 11701000 10443000 10605000 15672000 3062000 2687000 54170000 24423000 9412000 66000 33901000 3627000 6461000 2536000 14582000 115277000 3120000 -12161000 -6000 -1035000 67000 -13135000 129381000 44217000 75149000 76409000 1260000 Net earnings (loss) 5076000 Depreciation & amortization of property & intangibles 3814000 Stock based compensation 688000 Asset write-downs 388000 Net loss (gain) on sale of assets or businesses -47000 Deferred tax provision (benefit) -2342000 Credit losses & accounts receivable allowances Accounts receivable -599000 Inventories -741000 Accounts payable & accrued liabilities -1061000 Other current & non-current assets -1144000 Other current & non-current liabilities 3407000 Net cash flows from operating activities 7439000 Additions to property, plant & equipment -1987000 Proceeds from the disposal of assets or businesses, net 116000 Acquisitions, net of cash acquired Purchases of investments -9688000 Sales of investments 11877000 Credit support agreements activity, net -798000 Other investing activities (primarily licenses & milestones) 19000 Net cash flows from investing activites -461000 Dividends to shareholders -6034000 Repurchase of common stock -3918000 Proceeds from short-term debt 12221000 Repayment of short-term debt -1361 1000 Proceeds from long-term debt, net of issuance costs 7674000 Repayment of long-term debt -501000 Proceeds from the exercise of stock options or employee withhol 254000 Credit support agreements activity, net -126000 Proceeds from Kenvue, Inc. initial public offering 4241000 Other financing activities -53000 Net cash flows from financing activities 147000 Effect of exchange rate changes on cash & cash equivalents -69000 Increase (decrease) in cash & cash equivalents 7056000 Increase (decrease) in cash, cash equivalents & restricted cash Cash & cash equivalents beginning of period 14127000 Cash & cash equivalents, end of period 21183000 Cash, cash equivalents & restricted cash, end of periodJohnson & Johnson (NYS: JNJ) Exchange rate used is that of the Year End reported date As Reported Quarterly Income Statement Report Date 07/02/2023 2nd Quarter Currency USD Audit Status Unaudited Consolidated Yes Scale Thousands Sales to customers 25530000 Cost of products sold 8212000 Gross profit (loss) 17318000 Selling, marketing & administrative expenses 6665000 Research & development expense 3829000 In-process research & development expenses Interest income 369000 Interest expense, net of portion capitalized 346000 Other income (expense), net 60000 Restructuring expenses 145000 Earnings (loss) before provision for taxes on income 6762000 Provision for (benefit from) taxes on income 1618000 Net earnings (loss) 5144000 Weighted average shares outstanding - basic 2598400 Weighted average shares outstanding - diluted 2625700 Year end shares outstanding 2598143 Net earnings (loss) per share - basic 1.98 Net earnings (loss) per share - diluted 1.96 Cash dividends per share 1.19